PIN47 Cost-Effectiveness of Telbivudine in First Line Treatment of HBEAG-Negative Patients with Chronic Hepatitis B (CHB) in the Turkish Healthcare Setting
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.233
https://www.valueinhealthjournal.com/article/S1098-3015(11)01795-5/fulltext
Section Title :
Infection
Section Order :
210
First Page :
A273
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01795-5&doi=10.1016/j.jval.2011.08.233